Results 171 to 180 of about 128,688 (309)

BETA ADRENERGIC RECEPTOR OF RABBIT THORACIC AORTA IN RELATION TO AGE

, 1973
O.D. Gulati, B. P. METHEW, H. M. PARIKH, V. S. R. Krishnamurty   +3 more
openalex   +1 more source

Dorsal Genital Nerve Stimulation as an Adjunctive Therapy to Control Neurogenic Detrusor Overactivity After Spinal Cord Injury

Artificial Organs, EarlyView.
People with spinal cord injury (SCI) experience bladder overactivity, which can cause incontinence. Dorsal genital nerve stimulation (DGNS) can suppress overactivity, providing a longer duration to reach a toilet. People with SCI trialed home‐based DGNS for 8 weeks. DGNS was effective in the laboratory, and participants found home‐based DGNS acceptable.
Sean Doherty, Evangeline Martinez, Sarah Knight, Richard Nobrega, Lynsey Duffell   +4 more
wiley   +1 more source

Chromogranin A deficiency attenuates tauopathy by altering epinephrine-alpha-adrenergic receptor signaling in PS19 mice. [PDF]

Nat Commun
Jati S, Munoz-Mayorga D, Shahabi S, Tang K, Tao Y, Dickson DW, Litvan I, Ghosh G, Mahata SK, Chen X.   +9 more
europepmc   +1 more source

Vasoreactivity as a Measure of Kidney Viability During Ex Vivo Normothermic Machine Perfusion

Artificial Organs, EarlyView.
This study aimed to investigate the influence of warm ischemic injury on renal vascular responsiveness to vasoactive drugs during normothermic machine perfusion (NMP). We found that the vascular responses to dopamine and norepinephrine could be used as objective indicators to assess kidney viability during NMP.
Isa M. van Tricht, Baran Ogurlu, Silke S. M. Wolfswinkel, Henri G. D. Leuvenink, Cyril Moers   +4 more
wiley   +1 more source

Development of novel alpha 2B adrenergic receptor ligands by using a palladium catalyzed Buchwald Hartwig amination with a brominated benzodiazepine. [PDF]

RSC Med Chem
Fernando MRT, Vincent AB, Harrington SG, Toriola MA, Medubi KM, Meyer MJ, Webb DA, Arnold LA.   +7 more
europepmc   +1 more source

Population‐Based Cohort Study for Development of National Retinopathy of Prematurity Screening Criteria

Acta Paediatrica, EarlyView.
ABSTRACT Aim Screening criteria for retinopathy of prematurity (ROP) vary among countries. Early detection of ROP and minimising the burden of screening are important. Methods We analysed data from very preterm infants born in Switzerland between 2006 and 2022.
R. Gerull, C. Sanchez, A. Atkinson, M. Schuler‐Barazzoni, M. Adams, F. Barcos Munoz, C. Gerth‐Kahlert, S. M. Schulzke, on behalf of the Swiss Neonatal Network, Ph. Meyer, L. Eisenhut, M. Bryant, A. Kidszun, T. Riedel, M. Gebauer, B. Rogdo, B. Wagner, R. E. Pfister, J.‐F. Tolsa, J. Schneider, M. Stocker, P. Gessler, B. Laubscher, J. Llor, A. Malzacher, A. Birkenmaier, L. Hegi, V. Bernet, M. Tomaske, D. Bassler, V. Cannizzaro, C. Hagmann   +31 more
wiley   +1 more source

The β-adrenergic receptor-SGK1 signaling pathway in brown adipocytes protects GOT1 from proteasomal degradation. [PDF]

Front Cell Dev Biol
Park CH, Park M, Collier JJ, Chang JS.
europepmc   +1 more source

Peroxisome Proliferator-Activated Receptor (Ppar)-ϒ Agonist, Irbesartan and Adiponectin Ameliorate Blood Pressure, Renal Excretory Function and Vasoactive Responses to Adrenergic Agonists and Angiotensin IIin Spontaneously Hypertensive Rats

, 2019
Sheryar Afzal, Munavvar Abdul Sattar, Javed A. Qureshi, Venkata Sathya Raju   +3 more
openalex   +1 more source

Safety pharmacology of acute mescaline administration in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims Psychedelics, including mescaline, may serve as novel treatments for depression and anxiety. However, data is scarce on the safety of mescaline. Methods The present pooled analysis included two double‐blind, randomized, placebo‐controlled studies with a total of 48 participants and 96 mescaline administrations. Single oral‐dose administrations (n =
Aaron Klaiber, Mélusine Humbert‐Droz, Laura Ley, Yasmin Schmid, Matthias E. Liechti   +4 more
wiley   +1 more source

Agmatine decreases long-term potentiation <i>via</i> α2-adrenergic receptor and imidazoline type 1 receptor in the hippocampus. [PDF]

Korean J Physiol Pharmacol
Chang W, An J, Jang SH, Kim M, Min SS.
europepmc   +1 more source